Searched over 200M research papers
10 papers analyzed
These studies suggest that breast cancer management involves screening, diagnosis, personalized treatment, and follow-up care, with molecular pathways and the tumor microenvironment playing crucial roles in progression.
20 papers analyzed
Mammographic Screening
Mammographic screening is a critical step in the early detection of breast cancer. It has been confirmed as a valuable tool in identifying breast cancer at an early stage, which can significantly improve treatment outcomes and survival rates . Early detection through mammography allows for the identification of tumors before they become palpable, thus facilitating timely intervention.
Histological Diagnosis
Once a suspicious lesion is detected through screening, a histological diagnosis is essential. This involves a biopsy to confirm the presence of cancer cells. The process of delivering this diagnosis to the patient is sensitive and ideally conducted by a breast surgeon using supportive communication models like the NURSE model.
Staging and Imaging
For patients with a high risk of recurrence, computed tomography (CT) is recommended for staging, in addition to conventional methods . Accurate staging is crucial as it determines the extent of the disease and guides the treatment plan.
Surgical Treatment
Surgical intervention remains a cornerstone in the treatment of primary breast cancer. Complete resection of the tumor is the goal, but recent guidelines suggest that a safety margin of several millimeters is not necessary, allowing for less extensive surgery . Axillary dissection is now reserved for specific cases, reducing the surgical burden on patients .
Radiotherapy
Radiotherapy is another critical component, with hypofractionated applications being recommended. This approach reduces the number of treatment sessions while maintaining efficacy .
Systemic Therapy
Adjuvant systemic therapy is indicated for patients with high-risk factors such as tumor grade, patient age, node status, Ki-67 antigen expression, hormone receptor status, and HER2 status . Endocrine therapy is recommended for all patients with hormone receptor-positive breast cancer, while chemotherapy and anti-HER2 therapy are considered based on the expected benefits and side effects .
Multidisciplinary Approach
The management of breast cancer involves a multidisciplinary team, including surgeons, oncologists, radiologists, and specialized nurses. This collaborative approach ensures comprehensive care, addressing both the physical and emotional needs of the patient .
Personalized Medicine
The shift towards personalized medicine is evident in the use of sophisticated diagnostics, including molecular imaging and genomic expression profiles, which enable improved tumor characterization and tailored treatment plans. This personalized approach aims to minimize recurrence and reduce treatment-associated morbidity.
Long-Term Follow-Up
Long-term follow-up is essential to monitor for recurrence and manage any long-term side effects of treatment. The use of innovative technologies like the one-step nucleic acid amplification (OSNA) system for intraoperative assessment of sentinel lymph nodes can reduce surgical burden and healthcare costs without compromising survival outcomes.
The steps of breast cancer management—from screening and diagnosis to treatment and follow-up—are critical in improving patient outcomes. Advances in early detection, personalized treatment approaches, and multidisciplinary care have significantly enhanced the management of breast cancer, reducing morbidity and mortality. Consistent implementation of updated guidelines and continued research into the effectiveness of these strategies are essential for ongoing improvements in breast cancer care.
Most relevant research papers on this topic